Literature DB >> 9892292

Limbic activation during cue-induced cocaine craving.

A R Childress1, P D Mozley, W McElgin, J Fitzgerald, M Reivich, C P O'Brien.   

Abstract

OBJECTIVE: Since signals for cocaine induce limbic brain activation in animals and cocaine craving in humans, the objective of this study was to test whether limbic activation occurs during cue-induced craving in humans.
METHOD: Using positron emission tomography, the researchers measured relative regional cerebral blood flow (CBF) in limbic and comparison brain regions of 14 detoxified male cocaine users and six cocaine-naive comparison subjects during exposure to both non-drug-related and cocaine-related videos and during resting baseline conditions.
RESULTS: During the cocaine video, the cocaine users experienced craving and showed a pattern of increases in limbic (amygdala and anterior cingulate) CBF and decreases in basal ganglia CBF relative to their responses to the non-drug video. This pattern did not occur in the cocaine-naive comparison subjects, and the two groups did not differ in their responses in the comparison regions (i.e., the dorsolateral prefrontal cortex, cerebellum, thalamus, and visual cortex).
CONCLUSIONS: These findings indicate that limbic activation is one component of cue-induced cocaine craving. Limbic activation may be similarly involved in appetitive craving for other drugs and for natural rewards.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9892292      PMCID: PMC2820826          DOI: 10.1176/ajp.156.1.11

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  61 in total

1.  On the role of ascending catecholaminergic systems in intravenous self-administration of cocaine.

Authors:  D C Roberts; M E Corcoran; H C Fibiger
Journal:  Pharmacol Biochem Behav       Date:  1977-06       Impact factor: 3.533

2.  Evidence for conditional neuronal activation following exposure to a cocaine-paired environment: role of forebrain limbic structures.

Authors:  E E Brown; G S Robertson; H C Fibiger
Journal:  J Neurosci       Date:  1992-10       Impact factor: 6.167

3.  Responding to drug-related stimuli in humans as a function of drug-use history.

Authors:  R N Ehrman; S J Robbins; A R Childress; A T McLellan; C P O'Brien
Journal:  NIDA Res Monogr       Date:  1991

4.  Modulation of the discriminative stimulus effects of cocaine by mu and kappa opioids.

Authors:  R D Spealman; J Bergman
Journal:  J Pharmacol Exp Ther       Date:  1992-05       Impact factor: 4.030

Review 5.  Functional heterogeneity in cingulate cortex: the anterior executive and posterior evaluative regions.

Authors:  B A Vogt; D M Finch; C R Olson
Journal:  Cereb Cortex       Date:  1992 Nov-Dec       Impact factor: 5.357

6.  Chronic cocaine alters limbic extracellular dopamine. Neurochemical basis for addiction.

Authors:  A Imperato; A Mele; M G Scrocco; S Puglisi-Allegra
Journal:  Eur J Pharmacol       Date:  1992-03-03       Impact factor: 4.432

7.  Psychosomatic disease and the visceral brain; recent developments bearing on the Papez theory of emotion.

Authors:  P D MacLEAN
Journal:  Psychosom Med       Date:  1949 Nov-Dec       Impact factor: 4.312

8.  Activation of the hippocampus in normal humans: a functional anatomical study of memory.

Authors:  L R Squire; J G Ojemann; F M Miezin; S E Petersen; T O Videen; M E Raichle
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-01       Impact factor: 11.205

9.  Conditioned release of neurotransmitters as measured by microdialysis.

Authors:  B G Hoebel; G P Mark; H L West
Journal:  Clin Neuropharmacol       Date:  1992       Impact factor: 1.592

10.  Using cue reactivity to screen medications for cocaine abuse: a test of amantadine hydrochloride.

Authors:  S J Robbins; R N Ehrman; A R Childress; C P O'Brien
Journal:  Addict Behav       Date:  1992 Sep-Oct       Impact factor: 3.913

View more
  501 in total

1.  Assessing treatment outcome: how do we interpret the data?

Authors:  G E Woody
Journal:  Curr Psychiatry Rep       Date:  1999-12       Impact factor: 5.285

Review 2.  Recent advances in the biology of addiction.

Authors:  S E Hemby
Journal:  Curr Psychiatry Rep       Date:  1999-12       Impact factor: 5.285

3.  Neuroadaptation. Incubation of cocaine craving after withdrawal.

Authors:  J W Grimm; B T Hope; R A Wise; Y Shaham
Journal:  Nature       Date:  2001-07-12       Impact factor: 49.962

4.  The circuitry mediating cocaine-induced reinstatement of drug-seeking behavior.

Authors:  K McFarland; P W Kalivas
Journal:  J Neurosci       Date:  2001-11-01       Impact factor: 6.167

5.  Transcriptional profiling in the human prefrontal cortex: evidence for two activational states associated with cocaine abuse.

Authors:  E Lehrmann; J Oyler; M P Vawter; T M Hyde; B Kolachana; J E Kleinman; M A Huestis; K G Becker; W J Freed
Journal:  Pharmacogenomics J       Date:  2003       Impact factor: 3.550

6.  Prefrontal glutamate release into the core of the nucleus accumbens mediates cocaine-induced reinstatement of drug-seeking behavior.

Authors:  Krista McFarland; Christopher C Lapish; Peter W Kalivas
Journal:  J Neurosci       Date:  2003-04-15       Impact factor: 6.167

Review 7.  Functional genomics and psychiatric illness.

Authors:  Wendy Hasenkamp; Scott E Hemby
Journal:  Prog Brain Res       Date:  2002       Impact factor: 2.453

8.  A reexamination of smoking before, during, and after pregnancy.

Authors:  Robert S Kahn; Laura Certain; Robert C Whitaker
Journal:  Am J Public Health       Date:  2002-11       Impact factor: 9.308

9.  Abnormal pain response in pain-sensitive opiate addicts after prolonged abstinence predicts increased drug craving.

Authors:  Zhen-Yu Ren; Jie Shi; David H Epstein; Jun Wang; Lin Lu
Journal:  Psychopharmacology (Berl)       Date:  2009-01-27       Impact factor: 4.530

Review 10.  Neural systems mediating the inhibition of cocaine-seeking behaviors.

Authors:  Victória A Muller Ewald; Ryan T LaLumiere
Journal:  Pharmacol Biochem Behav       Date:  2017-07-15       Impact factor: 3.533

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.